Your browser doesn't support javascript.
loading
Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma.
Shoushtari, Alexander N; Friedman, Claire F; Navid-Azarbaijani, Pedram; Postow, Michael A; Callahan, Margaret K; Momtaz, Parisa; Panageas, Katherine S; Wolchok, Jedd D; Chapman, Paul B.
Affiliation
  • Shoushtari AN; Department of Medicine, Melanoma, and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Friedman CF; Weill Cornell Medical College, New York, New York.
  • Navid-Azarbaijani P; Department of Medicine, Melanoma, and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Postow MA; Weill Cornell Medical College, New York, New York.
  • Callahan MK; Department of Medicine, Melanoma, and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Momtaz P; Weill Cornell Medical College, New York, New York.
  • Panageas KS; Department of Medicine, Melanoma, and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Wolchok JD; Weill Cornell Medical College, New York, New York.
  • Chapman PB; Department of Medicine, Melanoma, and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center, New York, New York.
JAMA Oncol ; 4(1): 98-101, 2018 Jan 01.
Article in En | MEDLINE | ID: mdl-28817755
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Drug-Related Side Effects and Adverse Reactions / Ipilimumab / Nivolumab / Melanoma Type of study: Clinical_trials / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: JAMA Oncol Year: 2018 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Drug-Related Side Effects and Adverse Reactions / Ipilimumab / Nivolumab / Melanoma Type of study: Clinical_trials / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: JAMA Oncol Year: 2018 Document type: Article Country of publication: